JOSEPH WILLIAMS: Open Payments
NPI 1235159583 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,838 in 215 payments from 20 companies in 2025. Trend: 2023 $3,852 · 2024 $6,497 · 2025 $4,838
Food & beverage: $4,750Education: $88
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $966 |
| Teva Pharmaceuticals USA, Inc. | 17 | $594 |
| Otsuka America Pharmaceutical, Inc. | 37 | $522 |
| Neurocrine BioSciences, Inc. | 18 | $493 |
| Janssen Pharmaceuticals, Inc | 13 | $326 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $312 |
| Corium, LLC | 15 | $286 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $253 |
| Axsome Therapeutics, Inc. | 9 | $212 |
| Vanda Pharmaceuticals Inc. | 8 | $206 |
Products named: VRAYLAR, INGREZZA, INVEGA SUSTENNA, REXULTI, Azstarys, AUSTEDO XR, TRINTELLIX, UZEDY.
Industry payments across CT — which companies pay providers there.
